Preferred Label : DC-OVA Vaccine;
NCIt definition : An autologous, multivalent dendritic cell vaccine targeting ovarian cancer with potential
immunostimulating and antineoplastic activities. DC-OVA vaccine is produced in vitro
by pulsing autologous dendritic cells with killed autologous primary ovarian tumors
as a source of tumor-associated antigens (TAAs); the pulsed DCs are then matured using
various cytokines. Upon administration, DC-OVA vaccine may stimulate a cytotoxic T
lymphocyte (CTL) response against ovarian cancer TAA-expressing ovarian cancer cells.;
NCI Metathesaurus CUI : CL376121;
Origin ID : C73986;
UMLS CUI : C2348036;
Semantic type(s)
concept_is_in_subset